BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 2099751)

  • 1. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.
    Burgert EO; Nesbit ME; Garnsey LA; Gehan EA; Herrmann J; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P
    J Clin Oncol; 1990 Sep; 8(9):1514-24. PubMed ID: 2099751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
    Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
    J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.
    Evans RG; Nesbit ME; Gehan EA; Garnsey LA; Burgert O; Vietti TJ; Cangir A; Tefft M; Thomas P; Askin FB
    J Clin Oncol; 1991 Jul; 9(7):1173-80. PubMed ID: 2045857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies.
    Cangir A; Vietti TJ; Gehan EA; Burgert EO; Thomas P; Tefft M; Nesbit ME; Kissane J; Pritchard D
    Cancer; 1990 Sep; 66(5):887-93. PubMed ID: 2201433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
    Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
    Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
    J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
    Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
    Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
    Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
    Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
    J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide].
    Sudanese A; Avella M; Toni A; Boriani S; Baldini N; Monesi M; Battistini A; Mancini A; Campanacci M
    Minerva Med; 1987 Apr; 78(7):473-82. PubMed ID: 3574734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of Ewing's sarcoma to sequential cyclophosphamide and adriamycin induction therapy.
    Hayes FA; Thompson EI; Hustu HO; Kumar M; Coburn T; Webber B
    J Clin Oncol; 1983 Jan; 1(1):45-51. PubMed ID: 6668483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study.
    Perez CA; Tefft M; Nesbit M; Burgert EO; Vietti T; Kissane J; Pritchard DJ; Gehan EA
    Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):141-9. PubMed ID: 7012102
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
    Bacci G; Ferrari S; Bertoni F; Donati D; Bacchini P; Longhi A; Brach Del Prever A; Forni C; Rimondini S
    J Clin Oncol; 2000 Feb; 18(4):885-92. PubMed ID: 10673532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol].
    Deméocq F; Carton P; Patte C; Oberlin O; Sarrazin D; Lemerle J
    Presse Med; 1984 Mar; 13(12):717-21. PubMed ID: 6231575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study.
    Nesbit ME; Perez CA; Tefft M; Burgert EO; Vietti TJ; Kissane J; Pritchard DJ; Gehan EA
    Natl Cancer Inst Monogr; 1981 Apr; (56):255-62. PubMed ID: 7029293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
    Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
    J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
    Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
    Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
    Craft AW; Cotterill SJ; Bullimore JA; Pearson D
    Eur J Cancer; 1997 Jun; 33(7):1061-9. PubMed ID: 9376188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.